Bone Metastasis

26 registered clinical trials studyying Bone Metastasis — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Spinal Palliation in Irradiation for Neoplastic Analgesia and Life Quality NCT06884332	Institut de Cancérologie de Lorraine	N/A
Not Yet Recruiting	Non Steroidal Anti-inflammatory Drugs in the Prevention of Bone Pain Flares After Palliative Radiotherapy NCT06903585	American University of Beirut Medical Center	Phase 2
Recruiting	Biomolecular Markers of Bone Metastasis NCT06806462	IRCCS Azienda Ospedaliero-Universitaria di Bologna	N/A
Completed	Feasibility Study of FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases NCT04592887	Varian, a Siemens Healthineers Company	N/A
Unknown	Zoledronic Acid Combined Radiotherapy for Bone Metastasis of Non-small Cell Lung Cancer NCT02480634	Daping Hospital and the Research Institute of Surgery of the Third Military Medical University	Phase 4
Completed	Spinal Metastasis as the First Presentation of Lung Malignancy: Clinical Characteristics and Postoperative Sur NCT07100444	Guangdong Provincial People's Hospital	—
Terminated	Validation of Radio-induced Damage Biomarkers NCT02999152	Centre Hospitalier Universitaire de Saint Etienne	N/A
Unknown	Evaluation of Sodium Fluoride PET in the Identification of Bone Metastases in Patients Having Undergone a Chol NCT02876991	Central Hospital, Nancy, France	N/A
Unknown	The OPTIMAL Study - A Prospective Cohort of Patients With Bone Metastases of the Long Bones NCT02705157	Leiden University Medical Center	—
Completed	Phase 3 Study on the Efficacy and Safety of Tanezumab in Patients With Cancer Pain Due to Bone Metastasis Who NCT02609828	Pfizer	Phase 3
Completed	Pain Management With Pecfent in the Prevention of Pain Induced by Position in Radiotherapy NCT02426697	Centre Henri Becquerel	Phase 3
Completed	Bone Pain Score Validation Initiative NCT02293642	iOMEDICO AG	—
Completed	A Study to Collect Data About Analgesia in Patients With Bone Metastasis NCT02774213	Tools4Patient	—
Completed	A Trial of MBC-11 in Patients With CIBD NCT02673060	Osteros Biomedica Ltd	Phase 1
Completed	Efficacy of Radiotherapy in Combination With Zoledronic Acid in Bone Metastasis Patients With Gastrointestinal NCT02784652	Severance Hospital	Phase 2
Completed	A Phase IV Post Approval Clinical Study of ExAblate Treatment of Metastatic Bone Tumors for the Palliation of NCT01833806	InSightec	N/A
Completed	Comparison of NaF PET-CT and Diffusion MRI in the Diagnosis of Bone Metastases (IMMETAOS) NCT02876731	Institut Jean-Godinot	N/A
Completed	Survey of XGEVA® Presrcibers in Europe to Evaluate Their Knowledge of the Summary of Product Characteristics P NCT01998607	Amgen	—
Completed	Antalgic Treatment of Painful Bone Metastases by US-guided High Intensity Focused Ultrasound (HIFU) NCT01765907	Theraclion	Phase 1
Terminated	Multicenter Study of Magnetic Resonance-guided High Intensity Focused Ultrasound for Pain Palliation of Bone M NCT01586273	Philips Healthcare	N/A
Completed	Magnetic Resonance-Guided High Intensity Focused Ultrasound for Palliation of Painful Skeletal Metastases NCT01309048	Philips Healthcare	Phase 1 / Phase 2
Completed	Duration of Suppression of Bone Turnover Following Treatment With Zoledronic Acid in Men With Metastatic CRPC NCT01062503	University Health Network, Toronto	—
Completed	Optimization of Radiotherapy in Treatment of Painful Bone Metastasis NCT00610272	International Atomic Energy Agency	Phase 3
Completed	Effect of Zoledronic Acid on Bone Metabolism in Patients With Bone Metastasis and Prostate or Breast Cancer NCT00334139	Novartis Pharmaceuticals	Phase 4
Completed	Chemoradiation for Bone Metastasis NCT01784393	Rabin Medical Center	Phase 2
Temporarily Not Available	Standardization Research of TCM Syndrome Differentiation and Treatment on Advanced Breast Cancer NCT02011880	Shanghai University of Traditional Chinese Medicine	—